Литература

1. Carreras E. The EBMT Handbook. Hematopoietic stem cell transplantation and cellular therapies. - 2019. DOI: 10.1007/978-3-030-02278-5.

2. Leung T. F. et al. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation//Bone marrow transplantation. - 2000. - Т. 25. - N. 2. - С. 167 - 172. DOI: 10.1038/SJ.BMT.1702119.

3. Rubin L. G. et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host//Clinical infectious diseases. - 2014. - Т. 58. - N. 3. - С. e44 - e100. DOI: 10.1093/cid/cit816.

4. de la R. Vaccinations//The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies. - 2019. - С. 207 - 219. DOI: 10.1007/978-3-030-02278-5_29.

5. Cordonnier C. et al. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)//The Lancet infectious diseases. - 2019. - Т. 19. - N. 6. - С. e200 - e212. DOI: 10.1016/S1473-3099(18)30600-5.

6. Beck C. R. et al. Influenza vaccination for immunocompromised patients: systematic review and metaanalysis by etiology//The Journal of infectious diseases. - 2012. - Т. 206. - N. 8. - С. 1250 - 1259. DOI: 10.1093/infdis/jis487.

7. Miller P. D. E. et al. Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes//Bone marrow transplantation. - 2017. - Т. 52. - N. 5. - С. 775 - 777. DOI: 10.1038/bmt.2016.362.

8. Mikulska M. et al. Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)//The Lancet Infectious Diseases. - 2019. - Т. 19. - N. 6. - С. e188 - e199. DOI: 10.1016/S1473-3099(18)30601-7.

9. Васильева, В.А. Вакцинация взрослых пациентов после алло-ТГСК/Васильева, В.А., Караваева О.С.//В кн.: Трансплантация аллогенных гемопоэтических стволовых клеток. Практическое руководство/под ред. Е.Н. Паровичниковой, Т.В. Гапоновой, М.Ю. Дрокова - М.: Практика, 2024. - с. 605 - 618.

10. Salisbury D., Ramsay M., Noakes K. Green book: immunisation against infectious disease. 2006//Printed in Great Britain. - С. 1 - 25.

11. Bonanni P. et al. Recommended vaccinations for asplenic and hyposplenic adult patients//Human vaccines & immunotherapeutics. - 2017. - Т. 13. - N. 2. - С. 359 - 368. DOI: 10.1080/21645515.2017.1264797.

12. Cesaro S. et al. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)//Leukemia. - 2022. - Т. 36. - N. 6. - С. 1467 - 1480. DOI: 10.1038/S41375-022-01578-1.

13. World Health Organization. WHO expert consultation on rabies: third report. - World Health Organization, 2018. - Т. 1012. DOI: 10.1016/J.VACCINE.2018.06.061.

14. Cesaro S. et al. Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)//Leukemia. - 2023. - Т. 37. - N. 9. - С. 1933 - 1938. DOI: 10.1038/s41375-023-01938-5.

15. Интернет-ресурс: https://www.immunize.org/ [дата обращения: 18.12.2024].

16. Интернет-ресурс: https://www.cdc.gov/ [дата обращения: 18.12.2024].

17. Интернет-ресурс: https://www.cdc.gov/pneumococcal/surveillance.html [дата обращения: 18.12.2024].

18. Copelan E. A. Hematopoietic stem-cell transplantation//New England Journal of Medicine. - 2006. - Т. 354. - N. 17. - С. 1813 - 1826. DOI: 10.1056/NEJMra052638.

19. Nichols W. G. et al. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy//Clinical infectious diseases. - 2004. - Т. 39. - N. 9. - С. 1300 - 1306. DOI: 10.1086/425004.

20. Youssef S. et al. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989 - 2005//Medicine. - 2007. - Т. 86. - N. 2. - С. 69 - 77. DOI: 10.1097/md.0b013e31803eb176.

21. Leung T. F. et al. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation//Bone marrow transplantation. - 2000. - Т. 25. - N. 2. - С. 167 - 172. DOI: 10.1038/sj.bmt.1702119.

22. Ogonek J. et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation//Frontiers in immunology. - 2016. - Т. 7. - С. 507. DOI: 10.3389/fimmu.2016.00507.

23. Geddes M., Storek J. Immune reconstitution following hematopoietic stem-cell transplantation//Best practice & research Clinical haematology. - 2007. - Т. 20. - N. 2. - С. 329 - 348. DOI: 10.1016/j.beha.2006.09.009.

24. Castermans E. et al. Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age//haematologica. - 2010. - Т. 96. - N. 2. - С. 298. DOI: 10.3324/haematol.2010.029702.

25. Ljungman P. et al. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. - 1994. DOI: 10.1182/blood.V84.2.657.657.

26. Ljungman P. et al. Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease//Bone marrow transplantation. - 2004. - Т. 34. - N. 7. - С. 589 - 593. DOI: 10.1038/sj.bmt.1704634.

27. Small T. N., Cowan M. J. Immunization of hematopoietic stem cell transplant recipients against vaccine-preventable diseases//Expert review of clinical immunology. - 2011. - Т. 7. - N. 2. - С. 193 - 203. DOI: 10.1586/eci.10.103.

28. Tomblyn M. Center for International Blood and Marrow Research; National Marrow Donor program; European Blood and MarrowTransplant Group; American Society of Blood and Marrow Transplantation; Canadian Blood and Marrow Transplant Group; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America; Association of Medical Microbiology and Infectious Disease Canada; Centers for Disease Control and Prevention. Guidelines for preventing infectious complications among hematopoietic cell...//Biol Blood Marrow Transplant. - 2009. - Т. 15. - С. 1143 - 1238.

29. Seggewiss R., Einsele H. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update//Blood, The Journal of the American Society of Hematology. - 2010. - Т. 115. - N. 19. - С. 3861 - 3868. DOI: 10.1182/blood-2009-12-234096.

30. Деордиева Е.А. и др. Современный взгляд на проблему вакцинопрофилактики пациентов после трансплантации гемопоэтических стволовых клеток и рекомендации к ее проведению в Российской Федерации//Педиатрия. Журнал им. Г.Н. Сперанского. - 2019. - Т. 98. - N. 3. - С. 134 - 144. DOI: 10.24110/0031-403X-2019-98-3-135-144.